ACTIVATION OF THE MITOCHONDRIAL CLPP PROTEASE IS SYNTHETICALLY LETHAL WITH HDAC1/2 INHIBITION IN GLIOBLASTOMA MODEL SYSTEMS

被引：0
作者：
Schiffgens, Salveena [1 ]
Trang Nguyen [1 ]
Shu, Chang [1 ]
Elena, Bianchetti [1 ]
Torrini, Consuelo [1 ]
Karpel-Massler, Georg [2 ]
Siegelin, Markus [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Ulm Univ, Med Ctr, Ulm, Germany
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-50
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [21] CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1
    Yang, Pei-Ming
    Lin, Pei-Jie
    Chen, Ching-Chow
    EPIGENETICS, 2012, 7 (04) : 390 - 399
  • [22] Design and synthesis of novel dual-target agents for HDAC1 and CK2 inhibition
    Purwin, M.
    Hernandez-Toribio, J.
    Coderch, C.
    Panchuk, R.
    Skorokhyd, N.
    Filipiak, K.
    de Pascual-Teresa, B.
    Ramos, A.
    RSC ADVANCES, 2016, 6 (71): : 66595 - 66608
  • [23] KPNB1 modulates the Machado–Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP
    Mahkameh Abeditashi
    Jonasz Jeremiasz Weber
    Priscila Pereira Sena
    Ana Velic
    Maria Kalimeri
    Rana Dilara Incebacak Eltemur
    Jana Schmidt
    Jeannette Hübener-Schmid
    Stefan Hauser
    Boris Macek
    Olaf Riess
    Thorsten Schmidt
    Cellular and Molecular Life Sciences, 2022, 79
  • [24] Mechanistic Insights Into Fetal Hemoglobin (HbF) Induction Through Chemical Inhibition Of Histone Deacetylase 1 and 2 (HDAC1/2)
    Shearstone, Jeffrey R.
    van Duzer, John H.
    Jones, Simon S.
    Jarpe, Matthew
    BLOOD, 2013, 122 (21)
  • [25] MTORC1/2 and HDAC1/2 inhibition as therapy for colorectal cancer with PIK3CA mutation
    Olson, Autumn M.
    DeStefanis, Rebecca A.
    DeZeeuw, Alyssa K.
    Payne, Susan N.
    Pasch, Cheri A.
    Clipson, Linda
    Deming, Dustin A.
    CANCER RESEARCH, 2022, 82 (12)
  • [26] Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
    Jia, Haiqun
    Pallos, Judit
    Jacques, Vincent
    Lau, Alice
    Tang, Bin
    Cooper, Andrew
    Syed, Adeela
    Purcell, Judith
    Chen, Yi
    Sharma, Shefali
    Sangrey, Gavin R.
    Darnell, Shayna B.
    Plasterer, Heather
    Sadri-Vakili, Ghazaleh
    Gottesfeld, Joel M.
    Thompson, Leslie M.
    Rusche, James R.
    Marsh, J. Lawrence
    Thomas, Elizabeth A.
    NEUROBIOLOGY OF DISEASE, 2012, 46 (02) : 351 - 361
  • [27] KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP
    Abeditashi, Mahkameh
    Weber, Jonasz Jeremiasz
    Sena, Priscila Pereira
    Velic, Ana
    Kalimeri, Maria
    Eltemur, Rana Dilara Incebacak
    Schmidt, Jana
    Huebener-Schmid, Jeannette
    Hauser, Stefan
    Macek, Boris
    Riess, Olaf
    Schmidt, Thorsten
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (08)
  • [28] HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population
    Ler, Ser Yeng
    Leung, Carol Ho Wing
    Khin, Lay Wai
    Lu, Guo-Dong
    Salto-Tellez, Manuel
    Hartman, Mikael
    Iau, Philip Tsau Choong
    Yap, Celestial T.
    Hooi, Shing Chuan
    ONCOLOGY REPORTS, 2015, 34 (05) : 2238 - 2250
  • [29] Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse
    Kumar, Vipendra
    Joshi, Tripti
    Vatsa, Naman
    Singh, Brijesh Kumar
    Jana, Nihar Ranjan
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [30] Hydroxytyrosol ameliorates stress-induced liver injury through activating autophagy via HDAC1/2 inhibition
    Fan, Li
    Zhao, Lijuan
    Zhu, Yangbo
    Li, Lin
    Yang, Xueping
    Ma, Ping
    Liu, Jian
    Zhao, Qingwei
    Li, Xiaobo
    FOOD & FUNCTION, 2024, 15 (09) : 5103 - 5117
12345